Completed OBSERVATIONAL NCT02119104

Prevenar (13v) Infant Drug Use Investigation

Prevenar (13v) Infant Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Sponsor: Pfizer

Conditions Infants

Updated 8 times since 2017 Last updated: Apr 5, 2017 Started: Mar 31, 2014 Primary completion: May 31, 2016 Completion: May 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Infants and is currently completed. Pfizer leads this study, which shows 8 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 3 earlier versions

Aug 2017 — Apr 2018 [monthly]

Completed NA
Feb 2017 — Aug 2017 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pfizer

Data source: Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.